BME Faculty of Mechanical Engineering enters into cooperation agreement with Egis Pharmaceuticals

Following the successful cooperation with BME's Faculty of Chemical Technology and Biotechnology, Egis Pharmaceuticals PLC has now entered a closer professional relationship with the Faculty of Mechanical Engineering. The purpose of the agreement is to support the practical training of students, to develop their competencies expected in the labour market, to promote students with promising performance, and to demonstrate the opportunities the pharmaceutical industry offers to young people with relevant technical qualifications.

The new cooperation with Egis contributes to the modernisation of the training programme of the Department of Building Services and Process Engineering. In addition to providing students with traineeship and factory visit opportunities, the pharmaceutical company’s specialists provide on-site education to students in several fields of expertise ranging from energy to chemical and pharmaceutical technology. Students will already have access to these new training opportunities in the upcoming autumn term.

“For the Budapest University of Technology and Economics, it is of utmost importance that our students get connected to major industrial players during their studies. The cooperation agreement signed with Egis not only reinforces our practice-oriented training programme but also 

sets a good example of how to establish a close relationship between higher education and industry to provide a career path to the professionals of the future,” 

BME Rector Hassan Charaf said.

“With to this cooperation, we can more effectively draw the attention of our students to our chemical energetics and chemical engineering specialisations by offering more practical topics and their deeper understanding in the form of bachelor and master theses,” said Tibor Poós, head of the Chemical Engineering professional group. “We also hope to further encourage students’ commitment to scientific research and see more of them participate in the PhD training programmes in the future,” he added.

“Egis Pharmaceuticals is a vertically integrated company, and our operations cover all areas of the pharmaceutical value chain. We research, develop, manufacture and deliver our medicines to patients. This alone indicates the wide range of professionals and the diverse know-how we need. Just think about the research and manufacturing of active ingredients and finished products, the essential energetics, material storage and logistics infrastructure related to them, and the increasingly automated and data-driven instrumentation,” said Csaba Poroszlai, CEO of Egis, at the signing of the agreement.

According to Egis Technical Director Zsolt Fehérdi, 

experience shows that a good impulse from the right place at the right time may have a decisive impact on a student’s life and may even set them on a specific career path. 

“We’d like to add our own impulse, both by contributing to the modernisation of the BME training programm and by sharing some more interesting, special characteristics of our work.”

Rector's Office, Communications Directorate